• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Shares Of Cannabis Companies Traded Higher; Here Are 101 Biggest Movers From Yesterday

    8/3/22 6:07:18 AM ET
    $ACB
    $ACON
    $AEHL
    $AEMD
    Medicinal Chemicals and Botanical Products
    Health Care
    Medical Specialities
    Health Care
    Get the next $ACB alert in real time by email

    Gainers

    • MMTec, Inc. (NASDAQ:MTC) shares gained 390.6% to close at $7.85 on Tuesday amid volatility in nano-cap Chinese stocks.
    • Applied DNA Sciences, Inc. (NASDAQ:APDN) surged 296.9% to settle at $2.80 after the company initiated analytical validation of a Company-developed, PCR-based monkeypox virus test that is specific for the genetic signature of the monkeypox virus.
    • AMTD IDEA Group (NYSE:AMTD) shares climbed 236.5% to close at $7.00 on Tuesday after jumping 18% on Monday. The company owns 90%+ of AMTD Digital.
    • AMTD Digital Inc. (NYSE:HKD) surged 126.3% to settle at $1,679.00 on continued upward volatility following the stock's July IPO.
    • Cazoo Group Ltd (NASDAQ:CZOO) gained 118.3% to close at $1.05 after the company reported Q2 sales up 145% year over year.
    • MDJM Ltd (NASDAQ:MDJH) jumped 90% to settle at $3.4207.
    • Intelligent Living Application Group Inc. (NASDAQ:ILAG) jumped 77.1% to close at $3.33 after dropping around 7% on Monday.
    • Lixiang Education Holding Co., Ltd. (NASDAQ:LXEH) gained 68% to settle at $4.35.
    • Fangdd Network Group Ltd. (NASDAQ:DUO) gained 63.5% to close at $3.40. FangDD replaced KPMG as its auditor with Audit Alliance.
    • Boqii Holding Limited (NYSE:BQ) surged 58.2% to close at $2.69.
    • Ostin Technology Group Co., Ltd. (NASDAQ:OST) jumped 56.3% to close at $2.75 after gaining 6% on Monday.
    • Aethlon Medical, Inc. (NASDAQ:AEMD) gained 44.2% to settle at $1.99 as monkeypox stocks continue to surge amid concerns over the virus. New York City on Saturday declared monkeypox a public health emergency.
    • ECMOHO Limited (NASDAQ:MOHO) jumped 43.1% to close at $0.1660.
    • Molecular Data Inc. (NASDAQ:MKD) gained 41.7% to settle at $0.6673.
    • Meihua International Medical Technologies Co., Ltd. (NASDAQ:MHUA) gained 39.5% to settle at $7.07. The company on Monday reported FY21 sales were up year over year.
    • Moxian (BVI) Inc (NASDAQ:MOXC) jumped 38% to close at $1.3799.
    • Aclarion, Inc. (NASDAQ:ACON) rose 36.7% to close at $1.30.
    • L&F Acquisition Corp. (NASDAQ:LNFA) shares jumped 35% to close at $14.40.
    • TDH Holdings, Inc. (NASDAQ:PETZ) gained 33.7% to settle at $2.62.
    •  
    • 36Kr Holdings Inc. (NASDAQ:KRKR) jumped 29.9% to settle at $1.65 after surging over 10% on Monday.
    • Berkshire Grey, Inc. (NASDAQ:BGRY) gained 29.2% to close at $2.30 after the company announced an expansion of its relationship with FedEx. The company has also granted FedEx a warrant to purchase common stock which vests incrementally.
    • Antelope Enterprise Holdings Limited (NASDAQ:AEHL) jumped 27% to settle at $1.27.
    • Leju Holdings Limited (NYSE:LEJU) gained 26.6% to close at $2.33.
    • Taoping Inc. (NASDAQ:TAOP) rose 26.5% to settle at $1.05.
    • Sentage Holdings Inc. (NASDAQ:SNTG) gained 26% to close at $0.7182.
    • Meta Data Limited (NYSE:AIU) jumped 25.7% to close at $1.37 amid volatility in nano-cap Chinese companies.
    • Precipio, Inc. (NASDAQ:PRPO) rose 24.6% to settle at $1.47.
    • Infobird Co., Ltd (NASDAQ:IFBD) surged 24% to close at $0.46. Infobird recently signed a channel partner agreement with Harbor Private Limited to sell the company's products in the Singapore market.
    • Missfresh Limited (NASDAQ:MF) gained 23.9% to settle at $0.1239.
    • Integrated Media Technology Limited (NASDAQ:IMTE) jumped 22.9% to close at $1.72.
    • Liberty TripAdvisor Holdings, Inc. (NASDAQ:LTRPB) rose 22.8% to close at $58.97 after jumping 187% on Monday.
    • Faraday Future Intelligent Electric Inc. (NASDAQ:FFIE) rose 21% to close at $2.42 after FF Top Holding and the company executed a non-binding term sheet for a proposed convertible term loan facility up to $600 million.
    • Sharps Technology, Inc. (NASDAQ:STSS) jumped 20.8% to settle at $1.22.
    • Genius Sports Limited (NASDAQ:GENI) gained 20.5% to close at $3.23.
    • AlloVir, Inc. (NASDAQ:ALVR) jumped 20.5% to settle at $5.53.
    • PAVmed Inc. (NASDAQ:PAVM) rose 20.3% to settle at $1.66.
    • Connexa Sports Technologies Inc. (NASDAQ:CNXA) gained 19.9% to close at $1.08.
    • Uber Technologies, Inc. (NYSE:UBER) jumped 18.9% to close at $29.25 after the company reported better-than-expected Q2 sales results and reported gross bookings up 33% year over year.
    • Locafy Limited (NASDAQ:LCFY) climbed 18.6% to close at $0.4653. Locafy recently announced preliminary unaudited revenue for the financial year ended June 30.
    • Vroom, Inc. (NASDAQ:VRM) surged 18.5% to close at $1.73.
    • Diebold Nixdorf, Incorporated (NYSE:DBD) surged 18.4% to close at $3.93 following upbeat Q2 earnings.
    • Reliance Global Group, Inc. (NASDAQ:RELI) gained 17.5% to settle at $0.9637. Reliance Global Group sees Q2 sales to double compared to the same period last year.
    • Lyft, Inc. (NASDAQ:LYFT) gained 16.3% to close at $16.16 in sympathy with Uber, which reported better-than-expected Q2 earnings results and announced that gross booking volume increased year over year.
    • Transocean Ltd. (NYSE:RIG) shares rose 16.2% to close at $3.74 after the company posted a narrower Q2 loss and announced $321 million contract for ultra-deepwater drillship deepwater conqueror.
    • Hyperfine, Inc. (NASDAQ:HYPR) gained 15.5% to settle at $1.49.
    • Lindblad Expeditions Holdings, Inc. (NASDAQ:LIND) jumped 14.3% to close at $8.24. Lindblad Expeditions recently reported worse-than-expected Q2 EPS results.
    • Sunworks, Inc. (NASDAQ:SUNW) gained 14% to close at $2.45.
    • Tilray Brands, Inc. (NASDAQ:TLRY) jumped 14% to close at $3.90. Senate Democrats in July rolled out a marijuana decriminalization bill, which helped lift the sector last month.
    • Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) gained 13.8% to close at $14.17 as the company posted a narrower-than-expected Q2 loss.
    • Lytus Technologies Holdings PTV. Ltd. (NASDAQ:LYT) jumped 13.7% to close at $3.15.
    • JAKKS Pacific, Inc. (NASDAQ:JAKK) gained 13.1% to close at $25.03.
    • Aurora Cannabis Inc. (NASDAQ:ACB) rose 13.1% to settle at $1.55. Senate Democrats in July rolled out a marijuana decriminalization bill, which helped lift the sector last month.
    • So-Young International Inc.. (NASDAQ:SY) rose 11.9% to settle at $0.8946.
    • TravelCenters of America Inc. (NASDAQ:TA) gained 11.8% to close at $47.47 after the company reported better-than-expected Q2 sales.
    • Repligen Corporation (NASDAQ:RGEN) gained 11.7% to close at $237.38 after the company reported better-than-expected Q2 results and raised FY22 guidance.
    • Pinterest, Inc. (NYSE:PINS) rose 11.6% to close at $22.31 after Elliott Investment Management announced they are now Pinterest's largest investor. The company also reported Q2 financial results and issued Q3 guidance.
    • Root, Inc. (NASDAQ:ROOT) gained 11.4% to close at $1.17.
    • Microvast Holdings, Inc. (NASDAQ:MVST) gained 11.3% to close at $2.95.
    • ZoomInfo Technologies Inc. (NASDAQ:ZI) jumped 11.2% to close at $41.97 as the company reported better-than-expected results for its second quarter and also raised its revenue guidance for FY22.
    • Harsco Corporation (NYSE:HSC) climbed 9.4% to close at $5.25 following Q2 earnings.
    • SunPower Corporation (NASDAQ:SPWR) rose 9.4% to close at $21.70 after the company reported better-than-expected Q2 sales results.
    • Consolidated Communications Holdings, Inc. (NASDAQ:CNSL) gained 8% to close at $7.15 after the company reported upbeat quarterly earnings and said its Clio Subsidiary entered an agreement for the sale of its interests in five wireless partnerships to Verizon for $490 million.
    • SNDL Inc. (NASDAQ:SNDL) gained 7.9% to close at $2.46. Senate Democrats in July rolled out a marijuana decriminalization bill, which helped lift the sector last month.
    • Berkeley Lights, Inc. (NASDAQ:BLI) jumped 7.3% to close at $4.84.
    • Sientra, Inc. (NASDAQ:SIEN) rose 6.3% to close at $0.9896.

     


    Losers

    • Ontrak, Inc. (NASDAQ:OTRK) shares dipped 43.7% to close at $0.7598 on Tuesday after the company announced a registered direct offering for aggregate gross proceeds of $4 million. The company is scheduled to report Q2 results on August 9.
    • Apexigen Inc. (NASDAQ:APGN) dropped 34.1% to close at $13.83.
    • Mobile Global Esports Inc. (NASDAQ:MGAM) shares fell 33.5% to close at $8.63 after jumping 16% on Monday.
    • Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) dipped 28.8% to close at $6.46 after the company posted a wider Q2 loss.
    • DZS Inc. (NASDAQ:DZSI) declined 26.5% to close at $14.37 after the company reported worse-than-expected Q2 results.
    • Comera Life Sciences Holdings, Inc. (NASDAQ:CMRA) fell 23.4% to close at $2.98.
    • Great Lakes Dredge & Dock Corporation (NASDAQ:GLDD) fell 23.1% to close at $9.99 after the company reported worse-than-expected Q2 sales results.
    • Better Therapeutics, Inc. (NASDAQ:BTTX) shares dipped 22% to close at $2.16. Better Therapeutics recently completed its clinical trial for BT-001, an investigational prescription digital therapeutic that is designed to use nCBT to treat type 2 diabetes.
    • GeoVax Labs, Inc. (NASDAQ:GOVX) dropped 21.5% to settle at $3.06.
    • FAT Brands Inc. (NASDAQ:FATBB) fell 20.8% to close at $11.85. The company recently posted a Q2 net loss of $8.2 million or $0.50 per share.
    • Daseke, Inc. (NASDAQ:DSKE) dipped 19% to close at $6.97 following Q2 results.
    • FiscalNote Holdings Inc. (NYSE:NOTE) shares declined 18.5% to close at $6.93. FiscalNote completed acquisition of Aicel Technologies.
    • Kopin Corporation (NASDAQ:KOPN) declined 18.5% to close at $1.54 as the company reported second-quarter FY22 revenue growth of 20% year-on-year of $11.9 million, missing the consensus of $12.6 million.
    • Enhabit, Inc. (NYSE:EHAB) dropped 18.2% to close at $14.70. Enhabit reported a 6.3% year-over-year decline in net service revenue.
    • Concord Medical Services Holdings Limited (NYSE:CCM) fell 18% to settle at $1.60.
    •  
    • Syneos Health, Inc. (NASDAQ:SYNH) declined 17.6% to settle at $65.20 as the company lowered its FY22 guidance.
    • Evolus, Inc. (NASDAQ:EOLS) fell 17.6% to close at $10.80 after the company reported worse-than-expected Q2 EPS results.
    • TimkenSteel Corporation (NYSE:TMST) fell 17.4% to close at $16.28 after KeyBanc downgraded the stock from Overweight to Sector Weight.
    • Oatly Group AB (NASDAQ:OTLY) dipped 17.4% to settle at $3.24 after the company reported worse-than-expected Q2 sales and issued FY22 sales guidance below estimates.
    • MAIA Biotechnology, Inc. (NASDAQ:MAIA) dropped 16.8% to close at $6.49. Maia Biotechnology received FDA Orphan Drug Designation for THIO for the treatment of small-cell lung cancer.
    • Titan International, Inc. (NYSE:TWI) fell 16.5% to close at $14.17 following weak quarterly sales.
    • Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM) dipped 15.9% to settle at $2.80. Reneo Pharmaceuticals recently reported results from the REN001 long-chain fatty acid oxidation disorders (LC-FAOD) study and provided additional development updates.
    • Astec Industries, Inc. (NASDAQ:ASTE) fell 15.2% to close at $41.50 after reporting a decline in quarterly earnings.
    • Otonomy, Inc. (NASDAQ:OTIC) fell 14.4% to close at $0.2493. Otonomy recently announced it will discontinue development of OTO-313 after the Phase 2 trial of OTO-313 in patients with tinnitus demonstrated no clinically meaningful improvement versus placebo for primary and secondary endpoints across all timepoints.
    • Aileron Therapeutics, Inc. (NASDAQ:ALRN) dipped 12.6% to close at $0.14.
    • Emergent BioSolutions Inc. (NYSE:EBS) dropped 11.6% to close at $30.26 following downbeat quarterly results.
    • Celyad Oncology SA (NASDAQ:CYAD) fell 11.4% to close at $2.17. Calyad Oncology recently said that the FDA has lifted the clinical hold on the company's CYAD-101-002 Phase 1b trial after the company made changes to the eligibility criteria for the trial.
    • Woodward, Inc. (NASDAQ:WWD) dipped 11% to close at $93.29 after the company issued FY22 guidance below estimates. The company said its Q3 profitability was impacted by labor and material inflation as well as global supply chain and labor disruption.
    • Molson Coors Beverage Company (NYSE:TAP) fell 10.5% to close at $53.44 after the company reported worse-than-expected Q2 sales results.
    • Zebra Technologies Corporation (NASDAQ:ZBRA) dipped 9.8% to close at $323.32 after the company issued Q3 guidance below estimates.
    • Credit Acceptance Corporation (NASDAQ:CACC) dropped 9.1% to close at $528.89 after reporting Q2 results.
    • Matson, Inc. (NYSE:MATX) fell 8.7% to close at $83.33 following Q2 results.
    • Sealed Air Corporation (NYSE:SEE) declined 8.7% to close at $56.17 following Q2 results.
    • Arconic Corporation (NYSE:ARNC) fell 7.8% to close at $28.06 as the company lowered its FY22 top-line outlook.
    • Credit Suisse Group AG (NYSE:CS) fell 6.4% to settle at $5.40. Credit Suisse Group recently reported quarterly losses of 62 cents per share.
    • Avis Budget Group, Inc. (NASDAQ:CAR) slipped 4.7% to close at $172.54. Avis Budget reported better-than-expected Q2 EPS and sales results.
    Get the next $ACB alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACB
    $ACON
    $AEHL
    $AEMD

    CompanyDatePrice TargetRatingAnalyst
    Tilray Brands Inc.
    $TLRY
    4/3/2026$10.00Neutral → Buy
    Roth Capital
    Tilray Brands Inc.
    $TLRY
    4/2/2026$10.00Neutral → Buy
    Roth Capital
    Woodward Inc.
    $WWD
    4/1/2026$440.00Overweight
    Wells Fargo
    Phathom Pharmaceuticals Inc.
    $PHAT
    3/27/2026$18.00Equal Weight → Overweight
    Barclays
    Great Lakes Dredge & Dock Corporation
    $GLDD
    3/26/2026$17.00Neutral → Underweight
    Analyst
    Lindblad Expeditions Holdings Inc.
    $LIND
    3/16/2026$25.00Outperform
    Oppenheimer
    Enhabit Inc.
    $EHAB
    3/6/2026$13.80Buy → Hold
    TD Cowen
    Pinterest Inc.
    $PINS
    3/2/2026Buy → Hold
    Argus
    More analyst ratings

    $ACB
    $ACON
    $AEHL
    $AEMD
    SEC Filings

    View All

    SEC Form PRE 14A filed by Aclarion Inc.

    PRE 14A - Aclarion, Inc. (0001635077) (Filer)

    4/3/26 5:02:23 PM ET
    $ACON
    Medical Specialities
    Health Care

    Rhythm Pharmaceuticals Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - RHYTHM PHARMACEUTICALS, INC. (0001649904) (Filer)

    4/3/26 3:06:53 PM ET
    $RYTM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 25-NSE filed by FiscalNote Holdings Inc.

    25-NSE - FiscalNote Holdings, Inc. (0001823466) (Subject)

    4/3/26 11:05:54 AM ET
    $NOTE
    Real Estate

    $ACB
    $ACON
    $AEHL
    $AEMD
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Rhythm Pharmaceuticals Announces Changes to Board of Directors

    -- Kim Popovits appointed as new Director; Ed Mathers to depart -- BOSTON, April 03, 2026 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine diseases, today announced changes to its Board of Directors, including the appointment of Kim Popovits and the departure of Ed Mathers. "We are thrilled to welcome Kim to our Board of Directors," said David Meeker, M.D., Chairman, President and Chief Executive Officer of Rhythm. "Kim brings decades of leadership experience across biotechnology, diagnostics and commercial innovation, with a proven track record

    4/3/26 9:00:00 AM ET
    $RYTM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Molson Coors Completes Acquisition of Atomic Brands, Maker of Monaco Cocktails

    Acquisition establishes Molson Coors as a top-five supplier in the fast-growing ready-to-drink cocktail segment* More than 80 Monaco team members to join Molson Coors, expected to strengthen U.S. sales capabilities Molson Coors Beverage Company ("Molson Coors" or "the Company") (NYSE:TAP, TAP.A)) has completed the acquisition of Atomic Brands Inc., maker of Monaco Cocktails ("Monaco"), officially welcoming the brand to its U.S. Beyond Beer portfolio. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260402540509/en/ The acquisition establishes Molson Coors as a top-five supplier in the fast-growing ready-to-drink cocktail segme

    4/2/26 4:11:00 PM ET
    $TAP
    Beverages (Production/Distribution)
    Consumer Staples

    Dr. Calvin Choi, Founder of AMTD IDEA, Re‑Appointed as the Chief President of the Hong Kong Island Youth United Association

    PARIS and NEW YORK and LONDON, April 2, 2026 /PRNewswire/ -- AMTD Group Inc. ("AMTD Group"), AMTD IDEA Group (NYSE:AMTD, SGX: HKB)), AMTD Digital Inc. (NYSE:HKD) and The Generation Essentials Group (", TGE", , NYSE:TGE, LSE: TGE), a subsidiary of AMTD Digital Inc., are pleased to announce that Dr. Calvin Choi, founder of AMTD IDEA, has been re-appointed as the Chief President of the Hong Kong Island Youth United Association (the "Association"). Recently, the Hong Kong Island Youth United Association formally approved its second-term honorary appointments and the new composition

    4/2/26 8:13:00 AM ET
    $AMTD
    $HKD
    $TGE
    Finance: Consumer Services
    Finance
    Newspapers/Magazines
    Consumer Discretionary

    $ACB
    $ACON
    $AEHL
    $AEMD
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Dhanasekaran Satish bought $41,080 worth of shares (200 units at $205.40), increasing direct ownership by 5% to 4,056 units (SEC Form 4)

    4 - ZEBRA TECHNOLOGIES CORP (0000877212) (Issuer)

    3/16/26 4:20:06 PM ET
    $ZBRA
    Industrial Machinery/Components
    Industrials

    Director Molson Andrew Thomas bought $93,338 worth of Class B Common Stock (2,000 units at $46.67), increasing direct ownership by 9% to 24,654 units (SEC Form 4)

    4 - MOLSON COORS BEVERAGE CO (0000024545) (Issuer)

    3/10/26 5:10:40 PM ET
    $TAP
    Beverages (Production/Distribution)
    Consumer Staples

    Director Dhanasekaran Satish bought $112,625 worth of shares (500 units at $225.25), increasing direct ownership by 15% to 3,856 units (SEC Form 4)

    4 - ZEBRA TECHNOLOGIES CORP (0000877212) (Issuer)

    3/3/26 4:17:18 PM ET
    $ZBRA
    Industrial Machinery/Components
    Industrials

    $ACB
    $ACON
    $AEHL
    $AEMD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Aklog Lishan

    4 - PAVmed Inc. (0001624326) (Issuer)

    4/3/26 6:53:45 PM ET
    $PAVM
    Medical/Dental Instruments
    Health Care

    SEC Form 4 filed by Ying Wei

    4 - Microvast Holdings, Inc. (0001760689) (Issuer)

    4/3/26 6:46:42 PM ET
    $MVST
    Industrial Machinery/Components
    Miscellaneous

    SEC Form 4 filed by Pan Yixin

    4 - Microvast Holdings, Inc. (0001760689) (Issuer)

    4/3/26 6:42:25 PM ET
    $MVST
    Industrial Machinery/Components
    Miscellaneous

    $ACB
    $ACON
    $AEHL
    $AEMD
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for VOQUEZNA issued to PHATHOM PHARMACEUTICALS INC

    Submission status for PHATHOM PHARMACEUTICALS INC's drug VOQUEZNA (ORIG-1) with active ingredient VONOPRAZAN FUMARATE has changed to 'Approval' on 07/17/2024. Application Category: NDA, Application Number: 218710, Application Classification: Type 9 - New Indication Submitted as Distinct NDA, Consolidated with Original NDA after Approval

    7/18/24 10:52:01 AM ET
    $PHAT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for VOQUEZNA TRIPLE PAK issued to PHATHOM PHARMACEUTICALS, INC

    Submission status for PHATHOM PHARMACEUTICALS, INC's drug VOQUEZNA TRIPLE PAK (ORIG-1) with active ingredient AMOXICILLIN; CLARITHROMYCIN; VONOPRAZAN has changed to 'Approval' on 05/03/2022. Application Category: NDA, Application Number: 215152, Application Classification: Type 1 - New Molecular Entity and Type 4 - New Combination

    5/11/22 10:51:07 AM ET
    $PHAT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for VOQUEZNA DUAL PAK issued to PHATHOM PHARMACEUTICALS, INC

    Submission status for PHATHOM PHARMACEUTICALS, INC's drug VOQUEZNA DUAL PAK (ORIG-1) with active ingredient AMOXICILLIN; VONOPRAZAN has changed to 'Approval' on 05/03/2022. Application Category: NDA, Application Number: 215153, Application Classification: Type 5 - New Formulation or New Manufacturer

    5/11/22 10:17:03 AM ET
    $PHAT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACB
    $ACON
    $AEHL
    $AEMD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Tilray upgraded by Roth Capital with a new price target

    Roth Capital upgraded Tilray from Neutral to Buy and set a new price target of $10.00

    4/3/26 10:44:58 AM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    Tilray upgraded by Roth Capital with a new price target

    Roth Capital upgraded Tilray from Neutral to Buy and set a new price target of $10.00

    4/2/26 7:55:13 AM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    Wells Fargo initiated coverage on Woodward with a new price target

    Wells Fargo initiated coverage of Woodward with a rating of Overweight and set a new price target of $440.00

    4/1/26 8:56:39 AM ET
    $WWD
    Industrial Machinery/Components
    Energy

    $ACB
    $ACON
    $AEHL
    $AEMD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Fangdd Network Group Ltd.

    SC 13G - Fangdd Network Group Ltd. (0001750593) (Subject)

    12/16/24 4:26:40 PM ET
    $DUO
    Real Estate
    Finance

    Amendment: SEC Form SC 13G/A filed by Fangdd Network Group Ltd.

    SC 13G/A - Fangdd Network Group Ltd. (0001750593) (Subject)

    12/16/24 4:24:27 PM ET
    $DUO
    Real Estate
    Finance

    Amendment: SEC Form SC 13G/A filed by Pinterest Inc.

    SC 13G/A - PINTEREST, INC. (0001506293) (Subject)

    12/6/24 10:11:26 AM ET
    $PINS
    Computer Software: Programming Data Processing
    Technology

    $ACB
    $ACON
    $AEHL
    $AEMD
    Leadership Updates

    Live Leadership Updates

    View All

    Rhythm Pharmaceuticals Announces Changes to Board of Directors

    -- Kim Popovits appointed as new Director; Ed Mathers to depart -- BOSTON, April 03, 2026 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine diseases, today announced changes to its Board of Directors, including the appointment of Kim Popovits and the departure of Ed Mathers. "We are thrilled to welcome Kim to our Board of Directors," said David Meeker, M.D., Chairman, President and Chief Executive Officer of Rhythm. "Kim brings decades of leadership experience across biotechnology, diagnostics and commercial innovation, with a proven track record

    4/3/26 9:00:00 AM ET
    $RYTM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Molson Coors Completes Acquisition of Atomic Brands, Maker of Monaco Cocktails

    Acquisition establishes Molson Coors as a top-five supplier in the fast-growing ready-to-drink cocktail segment* More than 80 Monaco team members to join Molson Coors, expected to strengthen U.S. sales capabilities Molson Coors Beverage Company ("Molson Coors" or "the Company") (NYSE:TAP, TAP.A)) has completed the acquisition of Atomic Brands Inc., maker of Monaco Cocktails ("Monaco"), officially welcoming the brand to its U.S. Beyond Beer portfolio. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260402540509/en/ The acquisition establishes Molson Coors as a top-five supplier in the fast-growing ready-to-drink cocktail segme

    4/2/26 4:11:00 PM ET
    $TAP
    Beverages (Production/Distribution)
    Consumer Staples

    PAVmed Appoints Joseph Virgilio to Lead Relaunched Medical Device Portfolio

    Medtech industry veteran to oversee development and commercialization of PAVmed's current and future medical device portfolio.Octeris, Inc. subsidiary formed to advance endoscopic esophageal imaging technology recently licensed from Duke University.NEW YORK, April 2, 2026 /PRNewswire/ -- PAVmed Inc. (NASDAQ:PAVM) ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital health sectors, today announced that it has appointed medical technology industry veteran Joseph Virgilio as Senior Vice President and Chief Business Officer, Medical Devices to oversee the development and commercialization of PAVmed's cur

    4/2/26 8:01:00 AM ET
    $LUCD
    $PAVM
    Medical/Dental Instruments
    Health Care

    $ACB
    $ACON
    $AEHL
    $AEMD
    Financials

    Live finance-specific insights

    View All

    PAVmed Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results

    PAVmed strengthened its capital structure and relaunched its medical device portfolio under new leadership Veris Health advanced strategic partnership with OSU and progressed implantable physiological monitor toward FDA submissionLucid Diagnostics expanded EsoGuard healthcare system access and clinical evidence base Conference call and webcast to be held today, March 30, at 8:30 AM ESTNEW YORK, March 30, 2026 /PRNewswire/ -- PAVmed Inc. (NASDAQ:PAVM) ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital health sectors, today provided a business update for the Company and its subsidiaries, Lucid Diagno

    3/30/26 8:00:00 AM ET
    $LUCD
    $PAVM
    Medical/Dental Instruments
    Health Care

    Oatly to Report First Quarter 2026 Financial Results on April 29, 2026

    MALMÖ, Sweden, March 30, 2026 (GLOBE NEWSWIRE) -- Oatly Group AB (NASDAQ:OTLY), the world's original and largest oat drink company, will report financial results for the first quarter ended March 31, 2026, on Wednesday April 29, 2026 before the U.S. market opens. Oatly will host a conference call and webcast at 8:00 a.m. ET on the same day to discuss the results. The conference call and simultaneous live webcast can be accessed on Oatly's Investors website at https://investors.oatly.com under "Events." The webcast will be archived for 30 days. About Oatly We are the world's original and largest oat drink company. For over 30 years, we have exclusively focused on developing expertise arou

    3/30/26 7:00:00 AM ET
    $OTLY
    Packaged Foods
    Consumer Staples

    Kopin Corporation Reports Fourth Quarter 2025 Financial Results

    Balance Sheet Strengthened with $56 Million Capital Raise; Strategic Partnerships Advancing Key Defense Projects; Government Shutdown Delayed Revenue Recognition on Select Orders Industrywide Kopin Corporation (NASDAQ:KOPN) ("Kopin" or the "Company"), a leading provider of application-specific optical systems and high-performance microdisplays for defense, training, enterprise, industrial, consumer and medical products, today announced preliminary unaudited financial results for its fourth quarter ended December 27, 2025. Fourth Quarter Financial Summary: $ in millions Q4 2025 Q4 2024 % Change Total Revenues $8.4 $14.6 (42%) Produc

    3/27/26 8:00:00 AM ET
    $KOPN
    Semiconductors
    Technology